Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
J Clin Endocrinol Metab
    October 2025
  1. CARRY PM, Kim S, Zwick NL, Buckner T, et al
    Increased Levels of the Vitamin D Metabolite Ratio are Protective Against Progression from Islet Autoimmunity to T1D.
    J Clin Endocrinol Metab. 2025 Oct 30:dgaf578. doi: 10.1210.
    >> Share

    September 2025
  2. VILLAGELIN D, Cooper DS
    Low Dose Methimazole in the Long-Term Management of Graves' Disease: Small doses, big benefits.
    J Clin Endocrinol Metab. 2025 Sep 10:dgaf503. doi: 10.1210.
    >> Share

    August 2025
  3. XU Y, Liu R, Huang L, Qin Y, et al
    Response to Letter to the Editor from Perros: Comprehensive Comparisons of Different Treatments for Active Graves Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
    J Clin Endocrinol Metab. 2025 Aug 11:dgaf456. doi: 10.1210.
    >> Share

  4. PERROS P
    Letter to the Editor from Perros: Comprehensive Comparisons of Different Treatments for Active Graves' Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
    J Clin Endocrinol Metab. 2025 Aug 11:dgaf455. doi: 10.1210.
    >> Share

  5. IGUDESMAN D, Nally LM, Grimshaw AA, Gunderson CG, et al
    Dietary patterns for weight and glycemic management in persons with type 1 diabetes: a meta-analysis of clinical trials.
    J Clin Endocrinol Metab. 2025 Aug 7:dgaf448. doi: 10.1210.
    >> Share

  6. MIYAMURA K, Ito M, Yamaoka H, Hisakado M, et al
    Impact of minimal dose strategy before anti-thyroid drug discontinuation on relapse risk in Graves' disease.
    J Clin Endocrinol Metab. 2025 Aug 1:dgaf433. doi: 10.1210.
    >> Share

  7. MYERS R, Yildiz M, Nuri Ozbek M, Manzoor J, et al
    Children with diabetes and at least one non-autoimmune feature should be considered for monogenic diabetes testing.
    J Clin Endocrinol Metab. 2025 Aug 1:dgaf430. doi: 10.1210.
    >> Share

    July 2025
  8. NAKHLEH A, Robenshtok E, Adler L, Ben David SS, et al
    Clinical Characteristics and Outcomes of Graves' Disease in Individuals with Prior Hypothyroidism.
    J Clin Endocrinol Metab. 2025 Jul 25:dgaf426. doi: 10.1210.
    >> Share

  9. KHORASHAD BS, Kaabi O, Gardner MD, Getahun D, et al
    Prevalence of Psychiatric Comorbidities in Females With Classic Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2025;110:e2562-e2569.
    >> Share

  10. TILLMAN JB, Beck RW, Polonsky WH, Calhoun P, et al
    Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis.
    J Clin Endocrinol Metab. 2025;110:2134-2146.
    >> Share

  11. WYCKOFF JA, Lapolla A, Asias-Dinh BD, Barbour LA, et al
    Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2025 Jul 13:dgaf288. doi: 10.1210.
    >> Share

  12. AL NOFAL A, Benkhadra K, Abbas A, Nduwimana MJ, et al
    A Systematic Review Supporting the Clinical Practice Guidelines on the Management of Preexisting Diabetes and Pregnancy.
    J Clin Endocrinol Metab. 2025 Jul 13:dgaf289. doi: 10.1210.
    >> Share

  13. MICHELS AW, Brusko TM, Evans-Molina C, Homann D, et al
    Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement.
    J Clin Endocrinol Metab. 2025 Jul 9:dgaf267. doi: 10.1210.
    >> Share

    May 2025
  14. KAEWKRASAESIN C, Hwang M, Vasandani C, Brown RJ, et al
    Clinical features, metabolic and autoimmune derangements in acquired partial lipodystrophy (Barraquer-Simons Syndrome).
    J Clin Endocrinol Metab. 2025 May 28:dgaf315. doi: 10.1210.
    >> Share

  15. HAI Y, Ma Q, Fang S, Bahramimehr F, et al
    High-Throughput Proteomics and Immunohistochemistry of Orbital Connective Tissue in Graves' Orbitopathy.
    J Clin Endocrinol Metab. 2025 May 21:dgaf299. doi: 10.1210.
    >> Share

  16. YIN Q, Zhu T, Song D, Fang S, et al
    Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED.
    J Clin Endocrinol Metab. 2025;110:1537-1549.
    >> Share

  17. ZHANG Y, Alzahrani M, Luu T, Fatunbi J, et al
    Dyslipidemia is associated with increased NK cell cytotoxicity and autoimmunity in women with recurrent pregnancy losses.
    J Clin Endocrinol Metab. 2025 May 15:dgaf283. doi: 10.1210.
    >> Share

    April 2025
  18. BUJNIS M, DeSalvo K, Neklason DW, Madsen MJ, et al
    Familial risk of Hashimoto's thyroiditis in a large genealogical database.
    J Clin Endocrinol Metab. 2025 Apr 28:dgaf251. doi: 10.1210.
    >> Share

  19. HIRUMA S, Watanabe N, Noh JY, Hirose R, et al
    Occurrence of Newly Diagnosed Thyroid Cancer Is Not Increased After Radioactive Iodine Therapy for Graves' Disease.
    J Clin Endocrinol Metab. 2025 Apr 11:dgaf231. doi: 10.1210.
    >> Share

  20. LEICHTER SB, Felton JL, Rasmussen CG, Rizzuto P, et al
    Establishing Screening Programs for Presymptomatic Type 1 Diabetes: Practical Guidance for Diabetes Care Providers.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf194. doi: 10.1210.
    >> Share

    March 2025
  21. ONENGUT-GUMUSCU S, Concannon P, Akolkar B, Erlich HA, et al
    The Type 1 Diabetes Genetics Consortium (T1DGC).
    J Clin Endocrinol Metab. 2025 Mar 21:dgaf181. doi: 10.1210.
    >> Share

  22. PETERS AL, Buzzetti R, Lee CJ, Pavo I, et al
    Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS.
    J Clin Endocrinol Metab. 2025;110:e962-e969.
    >> Share

  23. KONDO T, Senokuchi T, Yano M, Takeda H, et al
    Benefits and Accuracy of Real-Time CGM in Children and Adolescents with Type 1 Diabetes Attending Summer Camp: 2nd year.
    J Clin Endocrinol Metab. 2025 Mar 12:dgaf160. doi: 10.1210.
    >> Share

  24. NIERVES LA, Lin TT, Moradian A, Shen Q, et al
    Biomarkers, Proteoforms, and Mass Spectrometry-based Assays for Diabetes Clinical Research.
    J Clin Endocrinol Metab. 2025 Mar 8:dgaf159. doi: 10.1210.
    >> Share

  25. MULLER NZ, Muresan IM, Kunzi A, Borojevic ZZ, et al
    Antibodies are predictive for diagnosis of celiac disease in pediatric type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Mar 8:dgaf146. doi: 10.1210.
    >> Share

  26. BERGMAN D, Kang X, Sun J, Ebrahimi F, et al
    Autoimmune Thyroid Diseases and Microscopic Colitis: A Nationwide Matched Case-Control Study in Sweden.
    J Clin Endocrinol Metab. 2025 Mar 5:dgaf140. doi: 10.1210.
    >> Share

  27. GATTA E, Pirola I, Gotti A, Fredi M, et al
    Clinical phenotype of Graves' disease in Autoimmune Polyglandular Syndrome or as isolated disease: the GRAPHE study.
    J Clin Endocrinol Metab. 2025 Mar 1:dgaf144. doi: 10.1210.
    >> Share

    February 2025
  28. HENSKE J, Turner LV, Riddell MC
    Approach to the Patient: Type 1 Diabetes Management with Exercise - Prepare, Perform, Stabilize, and Study.
    J Clin Endocrinol Metab. 2025 Feb 28:dgaf136. doi: 10.1210.
    >> Share

  29. RAFI E, Tranchito L, Hatipoglu B
    Navigating Insulin Options for Diabetes Management.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  30. LUNDGRIN EL, Kelly CA, Bellini N, Lewis C, et al
    Diabetes Technology Trends: A Review of the Latest Innovations.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  31. GALDERISI A, Bonet J, Ismail HM, Moran A, et al
    Metabolic phenotype of Stage 1 and Stage 2 type 1 diabetes using modelling of beta cell function.
    J Clin Endocrinol Metab. 2025 Feb 24:dgaf086. doi: 10.1210.
    >> Share

  32. HUMBERT L, Proust-Lemoine E, Dubucquoi S, Kemp EH, et al
    Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort.
    J Clin Endocrinol Metab. 2025;110:e757-e773.
    >> Share

  33. CAMOIN M, Mohammedi K, Saulnier PJ, Hadjadj S, et al
    Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population.
    J Clin Endocrinol Metab. 2025 Feb 4:dgae852. doi: 10.1210.
    >> Share

    January 2025
  34. DIEDISHEIM M, Mallone R, Pugliese A, Dubois-Laforgue D, et al
    Insulitis and exocrinitis in autoantibody-positive non-diabetic individuals: role of HLA genotypes.
    J Clin Endocrinol Metab. 2025 Jan 28:dgaf039. doi: 10.1210.
    >> Share

  35. SASO-JIMENEZ L, Urrutia I, Calvo B, Bilbao JR, et al
    Searching for monogenic autoimmune etiology in patients with type 1 diabetes onset under 30 months of age.
    J Clin Endocrinol Metab. 2025 Jan 28:dgaf049. doi: 10.1210.
    >> Share

  36. SAARI V, Alanko V, Holopainen E, Makitie O, et al
    Progressive Impairment of Prepubertal Growth in Children With APECED.
    J Clin Endocrinol Metab. 2025;110:e257-e265.
    >> Share

  37. LEWIS C, Rafi E, Dobbs B, Barton T, et al
    Tailoring Exercise Prescription for Effective Diabetes Glucose Management.
    J Clin Endocrinol Metab. 2025 Jan 21:dgae908. doi: 10.1210.
    >> Share

  38. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
    Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls.
    J Clin Endocrinol Metab. 2025 Jan 20:dgaf030. doi: 10.1210.
    >> Share

  39. ABU IRSHEED G, Steffen A, Martyn-Nemeth P, Park M, et al
    Multidimensional Sleep Health, Glycemic Control, and Self-Reported Outcomes in Type 1 Diabetes: A Cross-Sectional Study.
    J Clin Endocrinol Metab. 2025 Jan 16:dgaf032. doi: 10.1210.
    >> Share

  40. JAHOOR F, Hsu JW, Keene KR, Peacock WF, et al
    Amino acids and CART distinguish A-beta+ Ketosis-Prone Diabetes from type 1 and type 2 diabetes during hyperglycemic crises.
    J Clin Endocrinol Metab. 2025 Jan 16:dgaf033. doi: 10.1210.
    >> Share

  41. WANG S, Zhang Y, Balati A, Li B, et al
    Effect of Sodium-Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf016. doi: 10.1210.
    >> Share

  42. GERA S, Rearson A, Baker G, Douvas JL, et al
    Changes in 90-Day Time in Range Among Youth with Type 1 Diabetes Initiating Different Automated Insulin Delivery Systems.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf006. doi: 10.1210.
    >> Share

  43. KIM S, Subramanian S
    Approach to Lipid Management in the Patient with Diabetes.
    J Clin Endocrinol Metab. 2025 Jan 11:dgaf018. doi: 10.1210.
    >> Share

  44. BARTALENA L, Smith TJ
    Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2025 Jan 9:dgaf009. doi: 10.1210.
    >> Share

  45. DICKENS LT, Gonzalez MG
    Approach to the Patient using Diabetes Technology in Pregnancy.
    J Clin Endocrinol Metab. 2025 Jan 7:dgae914. doi: 10.1210.
    >> Share

  46. AMENDOLARA R, D'Onofrio L, Sessa RL, Di Giulio S, et al
    IFN-alpha neutralizing antibodies distinguish LADA from early-onset type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Jan 6:dgaf001. doi: 10.1210.
    >> Share

  47. ORSOS I, Molnar Z, Ujhelyi B, Steiber Z, et al
    Stimulation of Piezo1 mechanosensitive channels inhibits adipogenesis in thyroid eye disease.
    J Clin Endocrinol Metab. 2025 Jan 2:dgae899. doi: 10.1210.
    >> Share

    December 2024
  48. PENG R, Xie P, Jin Z, Zhou W, et al
    Significance of Thyroid Stimulating Immunoglobulin and Thyrotropin Receptor Antibody in Graves' Disease.
    J Clin Endocrinol Metab. 2024 Dec 23:dgae892. doi: 10.1210.
    >> Share

  49. HUANG J, Su A, Yang J, Zhuang W, et al
    Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment.
    J Clin Endocrinol Metab. 2024;110:159-165.
    >> Share

  50. YU B, Wang Y, Jin J, Liu J, et al
    CD34+ orbital fibroblasts contribute to the pathogenesis of thyroid eye disease via miR-182-5p.
    J Clin Endocrinol Metab. 2024 Dec 18:dgae876. doi: 10.1210.
    >> Share

  51. XU Y, Liu R, Huang L, Qin Y, et al
    Comprehensive Comparisons of Different Treatments for Active Graves' Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
    J Clin Endocrinol Metab. 2024 Dec 16:dgae877. doi: 10.1210.
    >> Share

  52. RAZVI SS, Wild H, Ingoe L, Vernazza J, et al
    Changes in thyroid function and autoimmunity in older individuals: longitudinal analysis of the Whickham cohort.
    J Clin Endocrinol Metab. 2024 Dec 14:dgae875. doi: 10.1210.
    >> Share

  53. YOSHIMURA K, Hirota Y, Saito S, Nishikage S, et al
    Prediction of insulin requirements by explainable machine learning for individuals with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Dec 11:dgae863. doi: 10.1210.
    >> Share

  54. FRANKS PW, Rich SS, Linder B, Zaghloul NA, et al
    A Research Roadmap to Address the Heterogeneity of Diabetes and Advance Precision Medicine.
    J Clin Endocrinol Metab. 2024 Dec 6:dgae844. doi: 10.1210.
    >> Share

  55. LIN YK, Ye W, Hepworth E, Rickels MR, et al
    Impaired Awareness and Symptomatology of Hypoglycemia in Adults with Type 1 Diabetes using Continuous Glucose Monitoring.
    J Clin Endocrinol Metab. 2024 Dec 5:dgae846. doi: 10.1210.
    >> Share

  56. GUO Y, Liu B, Liang W, Cheng Y, et al
    2'-O-Galloylhyperin Prevents Tissue Remodeling in Thyroid Eye Disease: Prospects as a Thyrotropin Receptor Antagonist.
    J Clin Endocrinol Metab. 2024 Dec 2:dgae732. doi: 10.1210.
    >> Share

    November 2024
  57. WANG V, Walsh J, Zell J, Verrilli LE, et al
    Autoimmune Disease is Increased in Women with Primary Ovarian Insufficiency.
    J Clin Endocrinol Metab. 2024 Nov 28:dgae828. doi: 10.1210.
    >> Share

  58. SMEW AI, Lundholm C, Gong T, Lichtenstein P, et al
    Glycaemic control and adult height: a nationwide Swedish cohort study on childhood type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae809. doi: 10.1210.
    >> Share

  59. YARDLEY JE, Li Z, Zaharieva DP, Riddell MC, et al
    Sex Differences in Glycemia and Self-Management Strategies for Exercise in an Active Adults Cohort with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Nov 14:dgae792. doi: 10.1210.
    >> Share

  60. WANG H, Li W, Chang P, Jia Q, et al
    Effect of methimazole withdrawl period on the I-131 uptake estimation using Tc-99m thyroid scanning in Graves' disease.
    J Clin Endocrinol Metab. 2024 Nov 11:dgae794. doi: 10.1210.
    >> Share

  61. PHAM UN, Pryke A, Baskerville T, Griffin A, et al
    Kidney hyperfiltration and mitochondrial changes are associated with eGFR decline in young people with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Nov 11:dgae787. doi: 10.1210.
    >> Share

    October 2024
  62. JOHNSON RJ, Bergford S, Gal RL, Calhoun P, et al
    The Role of Whole Food Plant-Based Food Intake on Postprandial Glycemia in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Oct 18:dgae725. doi: 10.1210.
    >> Share


  63. Correction to: "Effects of Low-dose Methotrexate With Methimazole in Patients With Graves' Disease: Results of a Randomized Clinical Trial".
    J Clin Endocrinol Metab. 2024 Oct 16:dgae698. doi: 10.1210.
    >> Share

  64. HUBER E, Singh T, Bunk M, Hebel M, et al
    Discrimination and precision of Continuous Glucose Monitoring in staging children with presymptomatic type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Oct 16:dgae691. doi: 10.1210.
    >> Share

  65. SUN A, Wang X, Qu J, Wu Y, et al
    The efficacy and safety of intravenous tocilizumab to treat Graves' ophthalmopathy: A systematic review and single-arm meta-analysis.
    J Clin Endocrinol Metab. 2024 Oct 14:dgae711. doi: 10.1210.
    >> Share

  66. PHAM-DOBOR G, Kaltenecker P, Temesfoi V, Bajnok L, et al
    Systematic analysis and network mapping of disease associations in autoimmune polyglandular syndrome.
    J Clin Endocrinol Metab. 2024 Oct 8:dgae701. doi: 10.1210.
    >> Share

    September 2024
  67. WEBER DR, O'Brien KO, Ballester L, Rackovsky N, et al
    Greater urinary calcium excretion is associated with diminished bone accrual in youth with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Sep 20:dgae660. doi: 10.1210.
    >> Share

  68. FENG J, Xu X, Cai W, Yang X, et al
    Inhibiting Soluble Epoxide Hydrolase Suppresses NF-kappaB p65 Signaling and Reduces CXCL10 Expression as a Potential Therapeutic Target in Hashimoto's Thyroiditis.
    J Clin Endocrinol Metab. 2024;109:2579-2588.
    >> Share

  69. XU L, Liu Z, Xu X, Wan Q, et al
    Thyroid autoimmunity is associated with dietary fat consumption.
    J Clin Endocrinol Metab. 2024 Sep 12:dgae629. doi: 10.1210.
    >> Share

  70. WEBB-ROBERTSON BM, Wu W, Flores JE, Bramer LM, et al
    RNA Splicing Events in Circulation Distinguish Individuals with and without New-Onset Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Sep 10:dgae622. doi: 10.1210.
    >> Share

  71. KARAKUS KE, Fleury T, Baschal EE, McDaniel KA, et al
    Clinical Features and HLA Genetics Differ in Children at Type 1 Diabetes Onset by Hispanic Ethnicity.
    J Clin Endocrinol Metab. 2024 Sep 4:dgae608. doi: 10.1210.
    >> Share

    August 2024
  72. MOOIJ CF, Zwaveling-Soonawala N, Hillebrand JJ, van Trotsenburg ASP, et al
    Approach to the Patient: Challenging Cases of Pediatric Thyrotoxicosis.
    J Clin Endocrinol Metab. 2024 Aug 27:dgae592. doi: 10.1210.
    >> Share

  73. ROMERES D, Ruchi FNU, Breton MD, Basu A, et al
    Post Prandial Glucose Turnover Differs Between Adolescents & Adults with Type 1 Diabetes: Triple Tracer Mixed Meal Study.
    J Clin Endocrinol Metab. 2024 Aug 22:dgae585. doi: 10.1210.
    >> Share

  74. HAO L, Xue J
    Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy".
    J Clin Endocrinol Metab. 2024 Aug 16:dgae554. doi: 10.1210.
    >> Share

  75. SMITH TJ, Holt RJ, Fu Q, Qashqai A, et al
    Assessment of hearing dysfunction in patients with Graves' disease and thyroid eye disease without or with teprotumumab.
    J Clin Endocrinol Metab. 2024 Aug 14:dgae560. doi: 10.1210.
    >> Share

  76. KAMIMOTO JLJ, Li Z, Gal RL, Castle JR, et al
    Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI Study.
    J Clin Endocrinol Metab. 2024;109:2233-2241.
    >> Share

  77. WU L, Carlino MS, Brown DA, Long GV, et al
    Response to Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy".
    J Clin Endocrinol Metab. 2024 Aug 13:dgae555. doi: 10.1210.
    >> Share

  78. ABU IRSHEED G, Martyn-Nemeth P, Baron KG, Reutrakul S, et al
    Sleep disturbances in type 1 diabetes and mitigating cardiovascular risk.
    J Clin Endocrinol Metab. 2024 Aug 6:dgae539. doi: 10.1210.
    >> Share

  79. HE X, Cao L, Fu X, Wu Y, et al
    The association between telomere length and diabetes mellitus: accumulated evidence from observational studies.
    J Clin Endocrinol Metab. 2024 Aug 1:dgae536. doi: 10.1210.
    >> Share

    July 2024
  80. ALVES JUNIOR JM, Bernardo W, Villagelin D
    "Effectiveness of Different Treatment Modalities in Initial and Chronic Phases of Thyroid Eye Disease: A Systematic Review with Meta-analysis".
    J Clin Endocrinol Metab. 2024 Jul 30:dgae526. doi: 10.1210.
    >> Share

  81. ISMAIL HM, Perera D, Mandal R, DiMeglio LA, et al
    Gut microbial changes associated with obesity in youth with type 1 diabetes: a Pilot Study.
    J Clin Endocrinol Metab. 2024 Jul 30:dgae529. doi: 10.1210.
    >> Share

  82. SHEN I, Usala RL, Mohseni M, Bouxsein ML, et al
    Adolescent girls with type 1 diabetes develop changes in bone prior to evidence of clinical neuropathy.
    J Clin Endocrinol Metab. 2024 Jul 26:dgae511. doi: 10.1210.
    >> Share

  83. D'ADDIO F, Lazzaroni E, Lunati ME, Preziosi G, et al
    Vaccinome landscape in nearly 620,000 patients with diabetes.
    J Clin Endocrinol Metab. 2024 Jul 23:dgae476. doi: 10.1210.
    >> Share

  84. LUPO MA, Olivo PD, Luffy M, Wolf J, et al
    US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease.
    J Clin Endocrinol Metab. 2024 Jul 19:dgae448. doi: 10.1210.
    >> Share

  85. ZHOU J, Chen W, Jiang WH, Wu Q, et al
    Altered Static and Dynamic Brain Functional Topological Organization in Patients With Dysthyroid Optic Neuropathy.
    J Clin Endocrinol Metab. 2024;109:2071-2082.
    >> Share

  86. SIMS EK, Cuthbertson D, Jacobsen L, Ismail HM, et al
    Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals.
    J Clin Endocrinol Metab. 2024;109:2116-2123.
    >> Share

  87. JONSDOTTIR B, Clasen JL, Vehik K, Lernmark A, et al
    Early appearance of thyroid autoimmunity in children followed from birth for type 1 diabetes risk.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae478. doi: 10.1210.
    >> Share

  88. XIE P, Shen L, Peng R, Wang Y, et al
    Effects of low-dose methotrexate with MMI in patients with Graves' disease: results of a randomized clinical trial.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae472. doi: 10.1210.
    >> Share

  89. AZIZI F, Mehran L, Abdi H, Amouzegar A, et al
    Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves' Disease.
    J Clin Endocrinol Metab. 2024 Jul 9:dgae456. doi: 10.1210.
    >> Share

  90. HORMAZABAL-AGUAYO I, Huerta-Uribe N, Munoz-Pardeza J, Ezzatvar Y, et al
    Association of physical activity patterns with nocturnal hypoglycemia events in youth with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Jul 2:dgae451. doi: 10.1210.
    >> Share

    June 2024
  91. VITALE RJ, Tinsley LJ, Volkening LK, Laffel LM, et al
    Lower Independent Self-Care Readiness Persists over Time in Teens with Type 1 Diabetes and Executive Function Challenges.
    J Clin Endocrinol Metab. 2024 Jun 12:dgae391. doi: 10.1210.
    >> Share

    May 2024
  92. MONTASER E, Farhy LS, Kovatchev BP
    Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics.
    J Clin Endocrinol Metab. 2024 May 31:dgae379. doi: 10.1210.
    >> Share

  93. XIE C, Huang W, Rayner CK, Horowitz M, et al
    Letter to the Editor From Xie et al: "The 13C Glucose Breath Test Accurately Identifies Insulin Resistance in People With Type 1 Diabetes".
    J Clin Endocrinol Metab. 2024 May 27:dgae366. doi: 10.1210.
    >> Share

  94. TRIOLO TM, Parikh HM, Tosur M, Ferrat L, et al
    Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives.
    J Clin Endocrinol Metab. 2024 May 20:dgae349. doi: 10.1210.
    >> Share

  95. CONOVER CA, Bale LK, Stan MN
    PAPP-A as a Potential Target in Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2024 May 16:dgae339. doi: 10.1210.
    >> Share

  96. PRIBITZER S, O'Rourke C, Ylescupidez A, Smithmyer M, et al
    Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 May 7:dgae292. doi: 10.1210.
    >> Share

    April 2024
  97. PETROVIC I, LoPresti J, Fatemi S, Gianoukakis A, et al
    Influence of Thyroglobulin (Tg) Autoantibodies on Tg levels Measured by Different Methodologies: (IMA, LC-MS/MS and RIA).
    J Clin Endocrinol Metab. 2024 Apr 30:dgae286. doi: 10.1210.
    >> Share

  98. LING P, Yang D, Wang C, Zheng X, et al
    Basal Hyperglycemia Contributes More Than Fifty Percent to Time in Range in Pregnant Women with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 30:dgae291. doi: 10.1210.
    >> Share

  99. HAGELQVIST PG, Andersen A, Maytham K, Andreasen CR, et al
    Hemostatic Effects of Exercise-Related Hypoglycemia in Male Persons With Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 20:dgae278. doi: 10.1210.
    >> Share

  100. DU X, Zhu Y, Lu W, Fu N, et al
    Regulation of the Function of T Follicular Helper Cells and B Cells in Type 1 Diabetes Mellitus by the OX40/OX40L Axis.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae248. doi: 10.1210.
    >> Share

  101. BAEK HS, Kim J, Jeong C, Lee J, et al
    Deep Learning Analysis with Gray Scale and Doppler Ultrasonography Images to Differentiate Graves' Disease.
    J Clin Endocrinol Metab. 2024 Apr 13:dgae254. doi: 10.1210.
    >> Share

  102. VILLAGELIN D, Cooper DS, Burch HB
    A 2023 International Survey of Clinical Practice Patterns in the Management of Graves' Disease: A Decade of Change.
    J Clin Endocrinol Metab. 2024 Apr 5:dgae222. doi: 10.1210.
    >> Share

    March 2024
  103. MATSUO Y, Miyawaki A, Watanabe H, Matsui H, et al
    Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study.
    J Clin Endocrinol Metab. 2024 Mar 28:dgae187. doi: 10.1210.
    >> Share

  104. THORNTON PS, De Leon DD, Empting S, Zangen D, et al
    Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.
    J Clin Endocrinol Metab. 2024;109:1071-1079.
    >> Share

  105. BROWN N, Elston MS
    Systematic Review-Type B Insulin Resistance With Isolated Hypoglycemia and Suppressed Insulin.
    J Clin Endocrinol Metab. 2024;109:936-943.
    >> Share

  106. MERTENS J, Roosens L, Braspenning R, Vandebeeck J, et al
    The 13C glucose breath test accurately identifies insulin resistance in people with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Mar 15:dgae175. doi: 10.1210.
    >> Share

  107. SOOY MGQ, Pyle L, Alonso GT, Broncucia HC, et al
    Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia.
    J Clin Endocrinol Metab. 2024 Mar 12:dgae158. doi: 10.1210.
    >> Share

  108. DAYAN CM
    The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease).
    J Clin Endocrinol Metab. 2024 Mar 7:dgad693. doi: 10.1210.
    >> Share

    February 2024
  109. KIM KM, Kim KJ, Han K, Rhee Y, et al
    Associations Between Physical Activity and the Risk of Hip Fracture Depending on Glycemic Status: A Nationwide Cohort Study.
    J Clin Endocrinol Metab. 2024;109:e1194-e1203.
    >> Share

  110. KONG YW, Yuan CY, Kiburg K, Brown K, et al
    Treatment satisfaction with Omnipod DASH in adults with type 1 diabetes: A non-blinded 1:1 randomized controlled trial.
    J Clin Endocrinol Metab. 2024 Feb 19:dgae088. doi: 10.1210.
    >> Share

  111. LV Y, Lu X, Liu G, Qi L, et al
    Differential diagnosis of post pancreatitis diabetes mellitus based on pancreatic and gut hormone characteristics.
    J Clin Endocrinol Metab. 2024 Feb 12:dgae080. doi: 10.1210.
    >> Share

  112. HELLEPUTTE S, Stautemas J, Jansseune L, De Backer T, et al
    Glycaemic management around postprandial exercise in people with type 1 diabetes: Challenge accepted.
    J Clin Endocrinol Metab. 2024 Feb 8:dgae079. doi: 10.1210.
    >> Share

    January 2024
  113. MAKINO H, Tohyama M, Kawamura R, Takata Y, et al
    Fulminant type 1 diabetes caused by DIHS could be affected by the reactivation of HHV-6.
    J Clin Endocrinol Metab. 2024 Jan 31:dgae058. doi: 10.1210.
    >> Share

  114. DOSIOU C
    "Teprotumumab for inactive thyroid eye disease? The jury is still out.".
    J Clin Endocrinol Metab. 2024 Jan 27:dgae052. doi: 10.1210.
    >> Share

  115. SHAH HS, McGill JB, Hirsch IB, Wu C, et al
    Poor glycemic control is associated with more rapid kidney function decline after the onset of diabetic kidney disease.
    J Clin Endocrinol Metab. 2024 Jan 23:dgae044. doi: 10.1210.
    >> Share

  116. CLINCK I, Mertens J, Wouters K, Dirinck E, et al
    Insulin resistance and CGM-derived parameters in people with type 1 diabetes: are they associated?
    J Clin Endocrinol Metab. 2024 Jan 10:dgae015. doi: 10.1210.
    >> Share

  117. ROMERES D, Yadav Y, Ruchi FNU, Carter R, et al
    Hyperglycemia suppresses Lactate Clearance during Exercise in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Jan 4:dgae005. doi: 10.1210.
    >> Share


  118. Correction to: "Ectopic Cervical Thymoma in a Patient Diagnosed With Graves Disease: A Systematic Literature Review".
    J Clin Endocrinol Metab. 2024 Jan 3:dgad759. doi: 10.1210.
    >> Share

    December 2023
  119. ZHANG Z, Luo S, Xiao Z, Yin W, et al
    Hsa_circRNA_405498 and hsa_circRNA_100033 serve as potential biomarkers for differential diagnosis of type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Dec 29:dgad761. doi: 10.1210.
    >> Share

  120. PEREA V, Vinagre I, Seres-Noriega T, Vinals C, et al
    Impact of preeclampsia and parity on sex-based discrepancies in subclinical carotid atherosclerosis in type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Dec 27:dgad755. doi: 10.1210.
    >> Share

  121. WEN X, Chang X, He X, Cai Q, et al
    Increased Thyroid DPP4 Expression is Associated with Inflammatory Process in Patients with Hashimoto's Thyroiditis.
    J Clin Endocrinol Metab. 2023 Dec 21:dgad723. doi: 10.1210.
    >> Share

  122. ZHAO L, Li W, Liu L, Duan L, et al
    Clinical Features and Outcome Analysis of Type B Insulin Resistance Syndrome: A Single-Center Study in China.
    J Clin Endocrinol Metab. 2023;109:e175-e181.
    >> Share

  123. OKSNES M, Husebye ES
    Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults.
    J Clin Endocrinol Metab. 2023;109:269-278.
    >> Share

  124. PAPARODIS R, Livadas S, Karvounis E, Bantouna D, et al
    Elevated Preoperative TPO Ab Titers Decrease Risk for DTC in a Linear Fashion: A Retrospective Analysis of 1635 Cases.
    J Clin Endocrinol Metab. 2023;109:e347-e355.
    >> Share

  125. TSAITLIN-MOR L, Cahen-Peretz A, Bentov Y, Ben-Shushan T, et al
    Long-Term Risk for Type 1 Diabetes and Obesity in Early Term Born Offspring: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2023 Dec 11:dgad715. doi: 10.1210.
    >> Share

  126. HOOPER AJ
    Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study".
    J Clin Endocrinol Metab. 2023 Dec 11:dgad719. doi: 10.1210.
    >> Share

  127. WU HX, Chu TY, Iqbal J, Jiang HL, et al
    Response to Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2023 Dec 9:dgad720. doi: 10.1210.
    >> Share

    November 2023
  128. WU L, Carlino MS, Brown DA, Long GV, et al
    Checkpoint inhibitor associated autoimmune diabetes mellitus is characterised by C-peptide loss and pancreatic atrophy.
    J Clin Endocrinol Metab. 2023 Nov 24:dgad685. doi: 10.1210.
    >> Share

  129. UHL S, Choure A, Rouse B, Loblack A, et al
    Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    J Clin Endocrinol Metab. 2023 Nov 21:dgad652. doi: 10.1210.
    >> Share

  130. LI P, Liu Y, Wei T, Wang X, et al
    Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.
    J Clin Endocrinol Metab. 2023 Nov 15:dgad667. doi: 10.1210.
    >> Share

  131. LAFONTAINE N, Shore CJ, Campbell PJ, Mullin BH, et al
    Epigenome-wide association study shows differential DNA methylation of MDC1, KLF9 and CUTA in autoimmune thyroid disease.
    J Clin Endocrinol Metab. 2023 Nov 14:dgad659. doi: 10.1210.
    >> Share

  132. MENON JC, Singh P, Archana A, Singh P, et al
    High frequency of recessive WFS1 mutations among Indian children with islet antibody-negative type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Nov 1:dgad644. doi: 10.1210.
    >> Share

    October 2023
  133. DOUGLAS RS, Couch S, Wester ST, Fowler BT, et al
    Efficacy and Safety of Teprotumumab in Thyroid Eye Disease Patients with Long Duration and Low Disease Activity.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad637. doi: 10.1210.
    >> Share

  134. NEMIROFF S, Chai R, Fan J, Ramer-Bass I, et al
    Ectopic Cervical Thymoma in a Patient Diagnosed with Graves Disease: A Systematic Literature Review.
    J Clin Endocrinol Metab. 2023 Oct 28:dgad635. doi: 10.1210.
    >> Share

  135. WU Q, Zhou J, Fang W, Jiang WH, et al
    Structural and functional brain changes after glucocorticoid therapy in thyroid-associated ophthalmopathy.
    J Clin Endocrinol Metab. 2023 Oct 21:dgad626. doi: 10.1210.
    >> Share

  136. BORCHERS J, Pukkala E, Makitie O, Laakso S, et al
    Epidemiology and Causes of Primary Adrenal Insufficiency in Children: A Population-Based Study.
    J Clin Endocrinol Metab. 2023;108:2879-2885.
    >> Share

  137. LUI DTW, Wong CKH, Man KKC
    Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
    J Clin Endocrinol Metab. 2023 Oct 17:dgad614. doi: 10.1210.
    >> Share

  138. MULLER I, Consonni D, Crivicich E, di Marco F, et al
    Response to Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
    J Clin Endocrinol Metab. 2023 Oct 17:dgad616. doi: 10.1210.
    >> Share


  139. Correction to "Autoimmune Diabetes From Chilhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype".
    J Clin Endocrinol Metab. 2023 Oct 13:dgad609. doi: 10.1210.
    >> Share

  140. VAN'T WESTEINDE A, Padilla N, Fletcher-Sandersjoo S, Kampe O, et al
    Increased resting-state functional connectivity in patients with autoimmune Addison's disease.
    J Clin Endocrinol Metab. 2023 Oct 11:dgad592. doi: 10.1210.
    >> Share


  141. Correction to "Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study".
    J Clin Endocrinol Metab. 2023 Oct 11:dgad596. doi: 10.1210.
    >> Share

  142. GORSHTEIN A, Turjeman A, Duskin-Bitan H, Leibovici L, et al
    Graves' disease following COVID-19 vaccination: a population-based, matched case-control study.
    J Clin Endocrinol Metab. 2023 Oct 10:dgad582. doi: 10.1210.
    >> Share

  143. ZHANG S, Zhao X, Wang X, Jin H, et al
    Gut microecology may be involved in pathogenesis of Hashimoto's thyroiditis by reducing production of hydrogen sulfide.
    J Clin Endocrinol Metab. 2023 Oct 4:dgad588. doi: 10.1210.
    >> Share


  144. Correction to: "OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals".
    J Clin Endocrinol Metab. 2023 Oct 4:dgad574. doi: 10.1210.
    >> Share

    September 2023
  145. NAESSEN S, Eliasson M, Berntorp K, Kitlinski M, et al
    Autoimmune disease in Turner syndrome in Sweden: An up to 25 years controlled follow-up study.
    J Clin Endocrinol Metab. 2023 Sep 27:dgad566. doi: 10.1210.
    >> Share

  146. MELING STOKLAND AE, Austdal M, Nedrebo BG, Carlsen S, et al
    Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.
    J Clin Endocrinol Metab. 2023 Sep 25:dgad538. doi: 10.1210.
    >> Share

  147. XIAO WC, Li X, Shan R, Mei F, et al
    Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
    >> Share

  148. WANG M, Jiang X, Geng J, Hui S, et al
    Outcomes of Patients With Dysthyroid Optic Neuropathy Treated With Intravenous Corticosteroids and/or Orbital Decompression Surgery: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2023;108:2717-2727.
    >> Share

  149. UELAND GA, Ueland HO, Stokland AM, Bhan A, et al
    Prevalence, risk factors, clinical and biochemical characteristics of Alemtuzumab-induced Graves' disease.
    J Clin Endocrinol Metab. 2023 Sep 14:dgad540. doi: 10.1210.
    >> Share

  150. SOUTH AM, Rigdon J, Voruganti S, Stafford JM, et al
    Uric Acid is Not Associated with Cardiovascular Health in Youth with Type 1 Diabetes: SEARCH for Diabetes in Youth Study.
    J Clin Endocrinol Metab. 2023 Sep 10:dgad534. doi: 10.1210.
    >> Share

  151. RAMZY A, Saber N, Bruin JE, Thompson DM, et al
    Thyroid hormone levels correlate with the maturation of implanted pancreatic endoderm cells in patients with type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Sep 6:dgad499. doi: 10.1210.
    >> Share

    August 2023
  152. FU J, Guan H
    The Impact of Salt Iodization on the Occurrence of Hyperthyroidism: Evidence from General Populations to Pregnant Women.
    J Clin Endocrinol Metab. 2023 Aug 31:dgad522. doi: 10.1210.
    >> Share

  153. MULLER I, Consonni D, Crivicich E, Di Marco F, et al
    Increased risk of Thyroid Eye Disease following Covid-19 Vaccination.
    J Clin Endocrinol Metab. 2023 Aug 25:dgad501. doi: 10.1210.
    >> Share

  154. HITT TA, Hannon TS, Magge SN
    Approach to the Patient with Youth-Onset Type 2 Diabetes.
    J Clin Endocrinol Metab. 2023 Aug 16:dgad482. doi: 10.1210.
    >> Share

  155. PARK J, Ntelis S, Yunasan E, Downton KD, et al
    Glucagon-like peptide 1 Analogues as Adjunctive Therapy for Patients with Type 1 Diabetes: an Updated Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2023 Aug 10:dgad471. doi: 10.1210.
    >> Share

  156. BILLINGS LK, Shi Z, Wei J, Rifkin AS, et al
    Utility of polygenic scores for differentiating diabetes diagnosis among patients with atypical phenotypes of diabetes.
    J Clin Endocrinol Metab. 2023 Aug 10:dgad456. doi: 10.1210.
    >> Share

  157. FISKER FA, Voss TS, Svart MV, Kampmann U, et al
    Insulin signaling is preserved in skeletal muscle during early diabetic ketoacidosis.
    J Clin Endocrinol Metab. 2023 Aug 9:dgad464. doi: 10.1210.
    >> Share

  158. BELLINI S, Guarrera S, Matullo G, Schalkwijk C, et al
    Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study.
    J Clin Endocrinol Metab. 2023 Aug 8:dgad468. doi: 10.1210.
    >> Share

    July 2023
  159. ETTINGER RA, Buitinga M, Vandamme C, Afonso G, et al
    Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study.
    J Clin Endocrinol Metab. 2023 Jul 20:dgad434. doi: 10.1210.
    >> Share

  160. HARTMANN B, Longo M, Mathiesen DS, Hare KJ, et al
    Signs of a Glucose and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2023 Jul 19:dgad431. doi: 10.1210.
    >> Share

  161. KRISTENSEN KB, Ranjan AG, McCarthy OM, Holst JJ, et al
    Effects of a low-carbohydrate-high-protein pre-exercise meal in type 1 diabetes - a randomised, crossover trial.
    J Clin Endocrinol Metab. 2023 Jul 18:dgad427. doi: 10.1210.
    >> Share

    June 2023
  162. KAHALY GJ, Dolman PJ, Wolf J, Giers BC, et al
    Proof-of-Concept and Randomized, Placebo-Controlled Trials of an Fcrn Inhibitor, Batoclimab, for Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2023 Jun 30:dgad381. doi: 10.1210.
    >> Share

  163. WANG Q, Chen Y, Xie Y, Xia Y, et al
    Type 2 diabetes family history as a significant index on the clinical heterogeneity differentiation in type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Jun 15:dgad363. doi: 10.1210.
    >> Share

  164. IMAGAWA A, Hanafusa T
    Fulminant type 1 diabetes - East and West.
    J Clin Endocrinol Metab. 2023 Jun 13:dgad329. doi: 10.1210.
    >> Share

  165. SIMMONS KM, Sims EK
    Screening and prevention of type 1 diabetes: Where are we?
    J Clin Endocrinol Metab. 2023 Jun 8:dgad328. doi: 10.1210.
    >> Share

    May 2023
  166. GIANDALIA A, Russo GT, Ruggeri P, Giancaterini A, et al
    The burden of obesity in type 1 diabetic subjects: a sex-specific analysis from the AMD Annals Initiative.
    J Clin Endocrinol Metab. 2023 May 29:dgad302. doi: 10.1210.
    >> Share

  167. ELEFTHERIOU A, Ong KK, Hughes IA, Petry CJ, et al
    Leptin and IGF-1 in infancy are associated with variants in DHCR7 and CYP2R1 that relate with type 1 diabetes and 25OHD.
    J Clin Endocrinol Metab. 2023 May 12:dgad263. doi: 10.1210.
    >> Share

  168. VERHOEFF K, Marfil-Garza BA, Czarnecka Z, Cuesta-Gomez N, et al
    Stem Cell-Derived Islet Transplantation in Patients with Type 2 Diabetes: Can Diabetes Subtypes Guide Implementation?
    J Clin Endocrinol Metab. 2023 May 12:dgad257. doi: 10.1210.
    >> Share

    April 2023
  169. WU HX, Chu TY, Iqbal J, Jiang HL, et al
    Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2023 Apr 24:dgad233. doi: 10.1210.
    >> Share

  170. DERELLA CC, Thomas J, Harris RA
    Women Have Greater Endothelin-B Receptor Function and Lower Mitochondrial Capacity Compared to Men with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2023 Apr 3:dgad189. doi: 10.1210.
    >> Share

    March 2023
  171. WRIGHT JJ, Dulaney A, Williams JM, Hilmes MA, et al
    Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2023 Mar 20:dgad150. doi: 10.1210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016